866-997-4948(US-Canada Toll Free)

Diabetic Macular Edema Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 316 Pages

Diabetic Macular Edema Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Diabetic Macular Edema Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Diabetic Macular Edema to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Diabetic Macular Edema to Metabolic Disorders Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 27
In Progress Trials by Phase 28
Clinical Trials by Trial Status 29
Clinical Trials by End Point Status 31
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Diabetic Macular Edema Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Diabetic Macular Edema 39
Jul 19, 2017: Positive Results Enable Alimera Sciences to Reduce Enrollment in ILUVIEN Registry Safety Study in the U.K. 39
Jul 11, 2017: Clearside Biomedical Announces First Patient Randomized in Phase 2 Clinical Trial of CLS-TA Used Together with Eylea in Patients with Diabetic Macular Edema 39
Jul 06, 2017: Opthea Receives Notice of Allowance for Key Patent Covering OPT-302 in the United States 39
Jun 26, 2017: Verseon Reveals Preclinical Data on Novel Drug Candidates to Treat Diabetic Macular Edema 40
May 24, 2017: ThromboGenics to present THR-317 Pre-clinical Research Findings at the European Association for the Study of Diabetes, Eye Complications Study Group Meeting in Budapest, Hungary 40
May 15, 2017: Isarna Presents Positive Clinical Data for ISTH0036 in Advanced Glaucoma and Preclinical Data Supportive of AMD/DME Potential at ARVO 2017 Annual Conference 40
May 03, 2017: Envisia Therapeutics Announces New Data On ENV1105 At ASCRS 2017 Annual Meeting 41
May 01, 2017: Alimera Sciences Announces Data From 27 ILUVIEN Studies to Be Presented at 2017 ARVO 41
Clinical Trial Profile Snapshots 44
Appendix 314
Abbreviations 314
Definitions 314
Research Methodology 315
Secondary Research 315
About GlobalData 316
Contact Us 316
Source 316

List of Tables
Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Region, 2017* 8
Diabetic Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
Diabetic Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Diabetic Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
Diabetic Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
Diabetic Macular Edema Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
Diabetic Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
Diabetic Macular Edema Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
Proportion of Diabetic Macular Edema to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 18
Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
Proportion of Diabetic Macular Edema to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 23
Diabetic Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Diabetic Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Phase, 2017* 27
Diabetic Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 28
Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2017* 30
Diabetic Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 33
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 35
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 37
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38

List of Figures
Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Diabetic Macular Edema Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Diabetic Macular Edema Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
Diabetic Macular Edema Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
Diabetic Macular Edema Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
Diabetic Macular Edema Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
Diabetic Macular Edema Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
Diabetic Macular Edema Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
Proportion of Diabetic Macular Edema to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017* 17
Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
Diabetic Macular Edema Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Diabetic Macular Edema to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017* 22
Diabetic Macular Edema Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
Diabetic Macular Edema Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Phase (%), 2017* 27
Diabetic Macular Edema Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 28
Diabetic Macular Edema Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Diabetic Macular Edema Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
Diabetic Macular Edema Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 33
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Diabetic Macular Edema Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38
GlobalData Methodology 315

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *